首页> 外文期刊>Pharmacology, Biochemistry and Behavior >Differential effects of dopamine receptor subtype-specific agonists with respect to operant behavior maintained on a differential reinforcement of low-rate responding (DRL) schedule
【24h】

Differential effects of dopamine receptor subtype-specific agonists with respect to operant behavior maintained on a differential reinforcement of low-rate responding (DRL) schedule

机译:多巴胺受体亚型特异性激动剂对操作行为的差异作用维持在低速应答(DRL)方案的差异增强上

获取原文
获取原文并翻译 | 示例
           

摘要

Previous studies have shown that d-amphetamine, a dopamine (DA) indirect agonist, alters operant responding with respect to the behavior maintained on a differential reinforcement of low-rate (DRL) schedule of reinforcement. These behavioral changes have been presumed to result from drug-induced hyperdopaminergia that leads to activation of DA receptors. This study investigated the acute dose effects of DA receptor subtype-selective agonists on the performance of DRL 10-sec behavior by rats. SKF38393 (a D1 receptor agonist) and quinpirole (a D2/D3 receptor agonist) were able to dose-dependently disrupt DRL 10-sec behavior by decreasing the total responses, the non-reinforced responses, and the peak rate of response. Bromocriptine (a D2/D3 receptor agonist) produced a significantly different pattern of behavioral changes when examined during two distinct time phases (15 min and 3 hr after the drug injection). DRL responding was only altered at higher doses of bromocriptine in the second phase as indicated by decreasing reinforced responses and peak rate, together with an increase of burst responses. In contrast to the Dl and D2/D3 receptor agonists, PD168077 (a D4 receptor agonist) did not affect DRL 10-sec behavior. None of these tested drugs affected DRL 10-sec behavior in a manner similar to that of d-amphetamine. These findings show that there are differential effects on the performance of DRL 10-sec behavior when drugs are able to preferentially activate Dl, D2/D3 and D4 receptors, supporting the assertion that there is functional heterogeneity of the DA receptor subtypes.
机译:先前的研究表明,多巴胺(DA)间接激动剂d-苯异丙胺会改变在低速(DRL)补强方案的补强方案下维持行为的操作响应。推测这些行为改变是由药物诱导的多巴胺痛引起的,该药物导致DA受体活化。这项研究调查了DA受体亚型选择性激动剂对大鼠DRL 10秒行为的急性剂量影响。 SKF38393(一种D1受体激动剂)和喹吡洛尔(一种D2 / D3受体激动剂)能够通过降低总响应,非增强响应和峰值响应速率来剂量依赖性地破坏DRL 10秒行为。在两个不同的时间阶段(药物注射后15分钟和3小时)进行检查时,溴隐亭(D2 / D3受体激动剂)产生了明显不同的行为变化模式。 DRL响应仅在第二阶段在较高剂量的溴隐亭中改变,这通过降低增强反应和峰值速率以及爆发响应增加来表明。与D1和D2 / D3受体激动剂相反,PD168077(D4受体激动剂)不影响DRL 10秒行为。这些测试药物均未以类似于d-苯异丙胺的方式影响DRL 10秒行为。这些发现表明,当药物能够优先激活D1,D2 / D3和D4受体时,对DRL 10秒行为的表现会有不同的影响,从而支持了DA受体亚型具有功能异质性的主张。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号